Here, we have modeled MCL-1 antagonism in breast cancer cell lines by inducible expression of a modified form (L62A/F69A double mutant) of the short isoform of BIM (BIMs2A/2A), which mimics the actions of a highly specific small molecule antagonist [15]. This evidence concerns the gene MCL1 and breast cancer.